Global Running News  Global Running News
Injuries and Treatment  Injuries
Nutrition Information  Nutrition
Running Training Information  Training
Running Information Forums  Forums

   Running Information      USA Running      Running South Africa      Running New Zealand      Running UK      Running Ireland      Running Ireland      Deutsch Laufzeit      Carrera española      Copenhagen Marathon      Suomen Juoksu      Sverige Löpning      Tel Aviv Marathon      Running Australia      Running Kenya      Running Europe      Running Malta      Running Namibia

Agency announces 2nd Quarter Testing number for 2005

Colorado Springs, Colo. (Sept, 2005) The United States Anti-Doping Agency (USADA) performed a total of 2,738 doping control tests in the second quarter (April 1- June 30) of 2005, including 2,575 domestic tests. The number of Out-of-Competition (OOC) domestic tests (1,288) was almost equal to the number of In-Competition (IC) domestic tests (1,287) completed during that period.

More than 93 percent of the OOC domestic testing was performed with no advance notice to the athlete. Testing completed at camps accounted for the remaining seven percent (85) of the OOC testing. OOC testing typically occurs at the athlete’s training facility or other location, based on information provided quarterly by approximately 2,500 athletes in the OOC testing pool.

USADA carried out 1,287 IC domestic tests at 79 domestic and international events during the second quarter, including the Boston Marathon, the Nike Prefontaine Classic, the 2005 World Swimming Championship Trials, and the U.S. National Wresting Championships.

On behalf of other anti-doping organizations, USADA conducted 163 tests on U.S. and non-U.S. athletes in the United States. USADA enlisted the assistance of international agencies to perform 11 tests on U.S. athletes living or training abroad.

In the second quarter, USADA announced six anti-doping rules violations, including one suspension involving the use of recombinant human erythropoietin (r-EPO), one suspension for the use of a stimulant, two suspensions for the prohibited use of cannabis, one suspension involving a beta-2 agonist, and another suspension for blood doping.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

USADA announces its testing numbers quarterly. Individual cases of alleged doping violations are announced at the time of the resolution. For the testing history of individual athletes, visit the official USADA Web site at

Source USADA